Hers vs Midi Health
Hers and Midi Health sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →
Midi Health
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Midi Health →If you are choosing between Hers and Midi Health, price alone will not settle it. Hers leads our six-part score, 7.0 to 4.6.
Hers vs Midi Health price
Hers publishes $199 a month. Midi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Hers lists semaglutide and tirzepatide; Midi Health does not name its drug.
On format, Hers prices compounded injections and brand-name pens, while Midi Health posts no priced format.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
Hers lists 50 states, and Midi Health lists 50 states.
They overlap in 50 states.
Pricing
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
Midi Health
Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. No compounded medication price is published on the current site.
Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.
What each price covers
Hers' price also covers the medication itself, which Midi Health does not claim.
Hers is silent on shipping and lab work.
Midi Health does not say what its price includes.
That matters most for the drug: unless Midi Health confirms otherwise, budget for medication on top of its listed price.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Midi Health
Inclusions not disclosed.
Where each one scores higher
Overall, Hers scores 7.0 and Midi Health 4.6 out of 10.
Hers is stronger on effectiveness (10.0 vs 5.0), user experience (8.0 vs 2.5) and trust & safety (8.5 vs 5.0).
Midi Health is stronger on support (5.0 vs 3.0).
Value and accessibility are within half a point.
Hers
7.0/10
Midi Health
4.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Hers nor Midi Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | Hers | Midi Health |
|---|---|---|
| Starting Price | $199/mo | Not published |
| Features | 2 features | ✓5 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →About Midi Health
Medicare, Medicaid, and Medi-Cal are all refused at Midi Health, though commercial insurance is taken. The platform covers menopause and perimenopause nationwide, in 50 states. GLP-1s are not sold here as a standalone weight-loss product; a clinician may add one at their discretion, a metabolic-health adjunct inside the menopause care framework.
Read our full Midi Health review →Pros & Cons
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- We found no FDA warning letters issued to Hers
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Midi Health
What we like
- Serves all 50 states
- We found no FDA warning letters issued to Midi Health
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hers wins this one, 7.0 to 4.6, above all for coverage in all 50 states, which most sellers will not confirm. Midi Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Choose Midi Health if…
You want coverage in all 50 states, which most sellers will not confirm.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Hers vs Midi Health: FAQ
Close alternatives to Hers and Midi Health
- Hers vs Hims
- Hers vs Noom
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
- Midi Health vs Embody
- Midi Health vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.